Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study
International Journal of Laboratory Hematology · 2024
DOI: 10.1111/ijlh.14188 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Izmarie Poventud-Fuentes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Iron Deficiencies, Anemia, Iron-Deficiency, Anemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
Detection of iron deficiency (ID) remains challenging. We aimed to evaluate the performance of reticulocyte hemoglobin equivalent (Ret‐He) as a potential diagnostic marker to assess ID and iron deficiency anemia (IDA) in a large pediatric cohort.
Methods
A total of 3158 patients (aged 15 days to 19 years with a median age of 8.5 years; 60.2% female) were retrospectively studied. Statistical analysis was performed (a) to evaluate relationship of Ret‐He with other relevant complete blood count and iron panel parameters; (b) to compare the levels of Ret‐He in ID and IDA groups to a control group; and (c) to assess sensitivity and specificity of Ret‐He in ID, IDA, and anemia without ID groups.
Results
Ret‐He values were significantly positively correlated to ferritin and transferrin saturation (TSAT). The median Ret‐He was significantly lower in ID. A Ret‐He cutoff of ≤30.0 pg distinguished cases of ID from the control group with a sensitivity of 90.2%, specificity of 59.5%, and area under curve (AUC) of 0.88. Ret‐He showed better diagnostic performance in the IDA group and acceptable performance for ID without anemia. The sensitivity, specificity, and AUC were 90.1%, 80.9%, and 0.93 for IDA at cutoff value of ≤27.4 pg, and 80.8%, 51.1%, and 0.70 for ID without anemia at cutoff value of ≤30.8 pg, respectively.
Conclusion
Our large pediatric tertiary care hospital study demonstrates that Ret‐He is a reliable marker to help confirm IDA in pediatric population. However, further studies are needed for its use to capture the early stages of ID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.
ORCID-Profile: Choladda V Curry
Zitieren
APA
Poventud-Fuentes, I., Chong, T. H., Dowlin, M., Devaraj, S., & Curry, C. V. (2024). Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14188
Vancouver
Poventud-Fuentes I, Chong TH, Dowlin M, Devaraj S, Curry CV. Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14188
BibTeX
@article{PoventudFuentes2024,
author = {Poventud-Fuentes, Izmarie and Chong, Thomas H and Dowlin, Michael and Devaraj, Sridevi and Curry, Choladda V},
title = {Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study},
journal = {International Journal of Laboratory Hematology},
year = {2024},
doi = {10.1111/ijlh.14188}
}
EUVIMED